Asymptomatic SARS-CoV-2 Detection in Children

NCT04853316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 372

Last updated 2022-11-02

No results posted yet for this study

Summary

The primary objective of this study is quantify the transmission risk posted by SARS-CoV-2 in pre/asymptomatic infected children in order to inform the public health response to the COVID-19 pandemic.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • University of Calgary

    lead OTHER

Principal Investigators

  • Stephen Freedman, MD · University of Calgary

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2022-04-22
Completion
2022-08-22

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04853316 on ClinicalTrials.gov